Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

30.62
+0.27000.89%
Post-market: 30.620.00000.00%16:10 EDT
Volume:707.56K
Turnover:21.62M
Market Cap:1.15B
PE:-30.64
High:31.11
Open:30.09
Low:29.90
Close:30.35
52wk High:54.85
52wk Low:28.54
Shares:37.49M
Float Shares:28.93M
Volume Ratio:1.32
T/O Rate:2.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9993
EPS(LYR):-0.1400
ROE:-116.07%
ROA:-0.45%
PB:75.52
PE(LYR):-218.71

Loading ...

Will Harrow’s (HROW) TYRVAYA Deal and Reaffirmed 2026 Guidance Redefine Its Dry Eye Strategy?

Simply Wall St.
·
Aug 18

Harrow Chief Scientific Officer Amir Shojaei Disposes of 11,250 Common Shares Worth $450,000

Reuters
·
Aug 18

Harrow Price Target Maintained with a $63.00/Share by BTIG

Dow Jones
·
Aug 12

Harrow, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Harrow Q2 Swings to Loss, Revenue Rises

MT Newswires Live
·
Aug 11

GUIDANCE: (HROW) Harrow Expects Full Year 2026 Revenue Range $350M - $365M, vs. FactSet Est of $348.5M

MT Newswires Live
·
Aug 11

Earnings Flash (HROW) Harrow Posts Q2 Loss $0.46, vs. FactSet Est of $0.18 Loss

MT Newswires Live
·
Aug 11

Harrow Q2 Revenue Slightly Beats Estimates

Reuters
·
Aug 11

Harrow Q2 EPS $(0.46) Misses $(0.21) Estimate, Sales $70.661M Beat $70.342M Estimate

Benzinga Earnings
·
Aug 11

Harrow Inc Q2 EPS USD -0.46

THOMSON REUTERS
·
Aug 11

Harrow Inc Q2 Gross Margin 71%

THOMSON REUTERS
·
Aug 11

B. Riley Securities Keeps Their Buy Rating on Harrow Health (HROW)

TIPRANKS
·
Aug 10

Analysts Are Bullish on These NA Stocks: Harrow Health (HROW), Caris Life Sciences, Inc. (CAI)

TIPRANKS
·
Aug 07

Arista Networks Stock Leads Fast Growth Picks With High Insider Ownership

Simply Wall St.
·
Aug 07

Viatris Sharpens Focus with Divestiture, Hikes 2026 Outlook

Benzinga Earnings
·
Aug 07

Viatris Raises Annual Profit Forecast on Branded Drug Strength

Reuters
·
Aug 06

Harrow to Buy Dry Eye Nasal Spray Tyrvaya from Viatris for up to $100 Million

Reuters
·
Aug 06

Harrow Inc: Expects to Fund Upfront Cash Payment Using Cash on Hand

THOMSON REUTERS
·
Aug 06

Harrow, - Deal Expected to Close in Second Half of 2026

THOMSON REUTERS
·
Aug 06

Harrow Acquires Global Rights to Tyrvaya®, the First and Only FDA-Approved Nasal Spray for Dry Eye Disease

THOMSON REUTERS
·
Aug 06